Company logo

APH - Alliance Pharma plc

LSE -> Healthcare -> Drug Manufacturers—Specialty & Generic
Chippenham, United Kingdom
Type: Equity

APH price evolution
APH
(in millions $) 29 Jun 2022 30 Mar 2022 30 Dec 2021 29 Sep 2021
Current assets
Cash $29.38 $29.38 $29.06 $29.06
Short term investments
Net receivables $42.31 $42.31 $27.72 $27.72
Inventory $23.04 $23.04 $21.07 $21.07
Total current assets $97.32 $97.32 $81.02 $81.02
Long term investments
Property, plant & equipment $4.8 $4.8 $4.46 $4.46
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $548.57 $548.57 $503.49 $503.49
Current liabilities
Accounts payable $11.57 $11.57 $8.34 $8.34
Deferred revenue
Short long term debt
Total current liabilities $50.45 $50.45 $40.58 $40.58
Long term debt $133 $133 $116.06 $116.06
Total noncurrent liabilities
Total debt
Total liabilities $251.64 $251.64 $221 $221
Shareholders' equity
Retained earnings $120.41 $120.41 $116.42 $116.42
Other shareholder equity $19.52 $19.52 $9.36 $9.36
Total shareholder equity $296.93 $296.93 $282.49 $282.49
(in millions $) 30 Dec 2021 30 Dec 2020 30 Dec 2019 30 Dec 2018
Current assets
Cash $29.06 $28.9 $17.83 $10.89
Short term investments
Net receivables $27.72 $24.22 $30.29 $27.93
Inventory $21.07 $22.92 $15.52 $18.71
Total current assets $81.02 $77.24 $65.04 $58.75
Long term investments
Property, plant & equipment $4.46 $4.49 $4.21 $3.34
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $503.49 $508.85 $407.64 $403.61
Current liabilities
Accounts payable $8.34 $11.28 $6.97 $8.98
Deferred revenue
Short long term debt $0.05 $68.03
Total current liabilities $40.58 $30.19 $24.21 $91.72
Long term debt $116.06 $138.33 $77.04 $28.67
Total noncurrent liabilities
Total debt
Total liabilities $221 $227.9 $133.46 $151.41
Shareholders' equity
Retained earnings $116.42 $117.7 $112.51 $95.1
Other shareholder equity $9.36 $7.28 $7.34 $7.28
Total shareholder equity $282.49 $280.96 $274.18 $252.2
(in millions $) 29 Jun 2022 30 Mar 2022 30 Dec 2021 29 Sep 2021
Revenue
Total revenue $39.38 $39.38 $42.29 $42.29
Cost of revenue $14.06 $14.06 $13.36 $13.36
Gross Profit $25.32 $25.32 $28.93 $28.93
Operating activities
Research & development
Selling, general & administrative $14.41 $14.41 $16.08 $16.08
Total operating expenses $31.28 $31.28 $32.3 $32.3
Operating income $8.1 $8.1 $9.99 $9.99
Income from continuing operations
EBIT $8.1 $8.1 $9.99 $9.99
Income tax expense $1.69 $1.69 $1.28 $1.28
Interest expense -$1.01 -$1.01 -$0.94 -$0.94
Net income
Net income $6.55 $6.55 -$0.46 -$0.46
Income (for common shares) $6.55 $6.55 -$0.46 -$0.46
(in millions $) 30 Dec 2021 30 Dec 2020 30 Dec 2019 30 Dec 2018
Revenue
Total revenue $163.21 $129.8 $135.64 $118.21
Cost of revenue $53.76 $46.98 $49.56 $45.56
Gross Profit $109.45 $82.82 $86.08 $72.65
Operating activities
Research & development
Selling, general & administrative $60.63 $44.61 $46.35 $41.93
Total operating expenses $125.16 $100.13 $97.91 $89.28
Operating income $38.05 $29.67 $37.73 $28.92
Income from continuing operations
EBIT $38.05 $29.67 $37.73 $28.92
Income tax expense $10.84 $4.99 $6.07 $4.45
Interest expense -$3.65 -$2.66 -$3.78 -$3.42
Net income
Net income $7.32 $8.03 $25.01 $18.36
Income (for common shares) $7.32 $8.03 $25.01 $18.36
(in millions $) 29 Jun 2022 30 Mar 2022 30 Dec 2021 29 Sep 2021
Net income $6.55 $6.55 -$0.46 -$0.46
Operating activities
Depreciation $2.19 $2.19 $2.03 $2.03
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $3.67 $3.67 $13.2 $13.2
Investing activities
Capital expenditures -$0.17 -$0.17 $1.38 $1.38
Investments
Total cash flows from investing -$8.02 -$8.02 -$0.51 -$0.51
Financing activities
Dividends paid -$1.51 -$1.51 -$2.87 -$2.87
Sale and purchase of stock
Net borrowings $6.59 $6.59 -$8.86 -$8.86
Total cash flows from financing $4.37 $4.37 -$12.28 -$12.28
Effect of exchange rate $0.13 $0.13 $0.42 $0.42
Change in cash and equivalents $0.16 $0.16 $0.84 $0.84
(in millions $) 30 Dec 2021 30 Dec 2020 30 Dec 2019 30 Dec 2018
Net income $7.32 $8.03 $25.01 $18.36
Operating activities
Depreciation $8.74 $8.91 $1.68 $1.55
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $38.66 $41.57 $35.76 $22.17
Investing activities
Capital expenditures -$1.53 -$4.61 -$4.14 -$2.89
Investments $0.5 $2.2
Total cash flows from investing -$4.6 -$85.86 -$3.28 -$59.08
Financing activities
Dividends paid -$8.6 -$2.84 -$7.6 -$6.35
Sale and purchase of stock
Net borrowings -$23.51 $60.17 -$18.2 $11.68
Total cash flows from financing -$34.34 $55.75 -$25.2 $36.59
Effect of exchange rate $0.45 -$0.38 -$0.34 $0.03
Change in cash and equivalents $0.16 $11.07 $6.94 -$0.29
Fundamentals
Market cap $25.96B
Enterprise value N/A
Shares outstanding 596.70M
Revenue $163.34M
EBITDA $44.62M
EBIT $36.18M
Net Income $12.18M
Revenue Q/Q 0.17%
Revenue Y/Y 11.33%
P/E ratio 2.13K
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 158.91
P/B ratio 93.57
Book/Share 0.46
Cash/Share 0.05
EPS $0.02
ROA 2.32%
ROE 4.21%
Debt/Equity 0.78
Net debt/EBITDA 4.98
Current ratio 1.93
Quick ratio 1.47